All In Biotech

Free tool

FAERS Monitor: Xarelto

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202439 or its brand name (Xarelto, Rivaroxaban). Reports on generic versions are filed under their own applications.

Reports

208,599

Serious

174,869

84% of reports

Hospitalization

104,161

Death reported

27,259

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • gastrointestinal haemorrhage21,673
  • off label use8,056
  • haemorrhage7,819
  • dyspnoea7,421
  • epistaxis6,806
  • fatigue6,801
  • death6,190
  • fall6,184
  • pulmonary embolism6,046
  • drug ineffective6,005
  • diarrhoea5,790
  • anaemia5,772
  • cerebrovascular accident5,648
  • dizziness5,584
  • nausea5,484

Reports by year received

View as table
YearReports
20074
20083
200952
201055
2011503
20123,861
20137,368
20149,409
201527,674
201629,714
201722,442
201821,010
201921,502
202014,671
202110,008
202210,492
20239,332
20248,319
20257,035
20265,145

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,845,560 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
gastrointestinal haemorrhageSignal21,67334.934.4531,471
epistaxisSignal6,80610.09.750,238
haemorrhageSignal7,8198.17.945,032
pulmonary embolismSignal6,0466.86.628,032
cerebrovascular accidentSignal5,6483.43.49,537
anaemiaSignal5,7723.13.08,112
fall6,1841.91.82,584
dyspnoea7,4211.31.3603
dizziness5,5841.11.185
off label use8,0560.90.948
diarrhoea5,7900.90.961
fatigue6,8010.90.9115
death6,1900.70.7683
nausea5,4840.70.7748
drug ineffective6,0050.50.44,115

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.